Reaction to the threat of influenza pandemic: the mass media and the public.

PubWeight™: 1.03‹?› | Rank: Top 15%

🔗 View Article (PMC 1550896)

Published in Crit Care on January 01, 2006

Authors

Matthew E Falagas, Ismene J Kiriaze

Articles by these authors

A bibliometric analysis of global research production in respiratory medicine. Chest (2005) 4.15

Severe cytomegalovirus infection in apparently immunocompetent patients: a systematic review. Virol J (2008) 3.60

Impact of the administration of probiotics on the incidence of ventilator-associated pneumonia: a meta-analysis of randomized controlled trials. Crit Care Med (2010) 3.43

Toxoplasmosis snapshots: global status of Toxoplasma gondii seroprevalence and implications for pregnancy and congenital toxoplasmosis. Int J Parasitol (2009) 3.27

Current control and treatment of multidrug-resistant Acinetobacter baumannii infections. Lancet Infect Dis (2008) 2.87

Counterfeit or substandard antimicrobial drugs: a review of the scientific evidence. J Antimicrob Chemother (2007) 2.79

Perspectives for the treatment of brucellosis in the 21st century: the Ioannina recommendations. PLoS Med (2007) 2.58

Combination therapy with intravenous colistin for management of infections due to multidrug-resistant Gram-negative bacteria in patients without cystic fibrosis. Antimicrob Agents Chemother (2005) 2.47

Comparison of amount of biomedical research originating from the European Union and the United States. BMJ (2005) 2.42

Bacterial infection-related morbidity and mortality in cirrhosis. Am J Gastroenterol (2007) 2.35

Deaths attributable to carbapenem-resistant Enterobacteriaceae infections. Emerg Infect Dis (2014) 2.29

Candida albicans versus non-albicans intensive care unit-acquired bloodstream infections: differences in risk factors and outcome. Anesth Analg (2008) 2.10

β-D-glucan assay for the diagnosis of invasive fungal infections: a meta-analysis. Clin Infect Dis (2011) 2.03

Carbapenems versus alternative antibiotics for the treatment of bacteraemia due to Enterobacteriaceae producing extended-spectrum β-lactamases: a systematic review and meta-analysis. J Antimicrob Chemother (2012) 2.01

Tigecycline for the treatment of multidrug-resistant Enterobacteriaceae: a systematic review of the evidence from microbiological and clinical studies. J Antimicrob Chemother (2008) 1.98

Pandrug resistance (PDR), extensive drug resistance (XDR), and multidrug resistance (MDR) among Gram-negative bacilli: need for international harmonization in terminology. Clin Infect Dis (2008) 1.91

Continuous versus intermittent intravenous administration of antibiotics: a meta-analysis of randomised controlled trials. Lancet Infect Dis (2005) 1.89

Estimates of global production in cardiovascular diseases research. Int J Cardiol (2005) 1.87

Predictors of mortality in patients with infections due to multi-drug resistant Gram negative bacteria: the study, the patient, the bug or the drug? J Infect (2012) 1.84

Epidemiology of constipation in Europe and Oceania: a systematic review. BMC Gastroenterol (2008) 1.77

Albendazole versus praziquantel in the treatment of neurocysticercosis: a meta-analysis of comparative trials. PLoS Negl Trop Dis (2008) 1.75

Effect of aminoglycoside and beta-lactam combination therapy versus beta-lactam monotherapy on the emergence of antimicrobial resistance: a meta-analysis of randomized, controlled trials. Clin Infect Dis (2005) 1.74

Unique author identification number in scientific databases: a suggestion. PLoS Med (2006) 1.73

Risk factors associated with the isolation of colistin-resistant gram-negative bacteria: a matched case-control study. Crit Care Med (2008) 1.69

Frequency, prevention, outcome and treatment of ventilator-associated tracheobronchitis: systematic review and meta-analysis. Respir Med (2010) 1.67

Fluconazole versus itraconazole for antifungal prophylaxis in neutropenic patients with haematological malignancies: a meta-analysis of randomised-controlled trials. Br J Haematol (2005) 1.60

Fluoroquinolones compared with beta-lactam antibiotics for the treatment of acute bacterial sinusitis: a meta-analysis of randomized controlled trials. CMAJ (2008) 1.60

Worldwide prevalence of head lice. Emerg Infect Dis (2008) 1.58

Aerosolized colistin for the treatment of nosocomial pneumonia due to multidrug-resistant Gram-negative bacteria in patients without cystic fibrosis. Crit Care (2005) 1.58

Tigecycline for the treatment of multidrug-resistant (including carbapenem-resistant) Acinetobacter infections: a review of the scientific evidence. J Antimicrob Chemother (2008) 1.56

Fosfomycin: evaluation of the published evidence on the emergence of antimicrobial resistance in Gram-negative pathogens. J Antimicrob Chemother (2011) 1.55

Comparison of first-line with second-line antibiotics for acute exacerbations of chronic bronchitis: a metaanalysis of randomized controlled trials. Chest (2007) 1.55

Impact of patient position on the incidence of ventilator-associated pneumonia: a meta-analysis of randomized controlled trials. J Crit Care (2009) 1.55

Colistin: recent data on pharmacodynamics properties and clinical efficacy in critically ill patients. Ann Intensive Care (2011) 1.54

Research contribution of different world regions in the top 50 biomedical journals (1995-2002). FASEB J (2006) 1.54

Prevalence of hepatitis B, hepatitis C, and HIV infections among patients in a psychiatric hospital in Greece. Psychiatr Serv (2009) 1.54

Attributable mortality of Acinetobacter baumannii infection among critically ill patients. Clin Infect Dis (2006) 1.52

Respiratory fluoroquinolones for the treatment of community-acquired pneumonia: a meta-analysis of randomized controlled trials. CMAJ (2008) 1.51

Impact of passive humidification on clinical outcomes of mechanically ventilated patients: a meta-analysis of randomized controlled trials. Crit Care Med (2007) 1.50

Effect of thiazolidinedione therapy on restenosis after coronary stent implantation: a meta-analysis of randomized controlled trials. Am Heart J (2007) 1.49

Bowel cleansing before bowel surgery: major discordance between evidence and practice. J Gastrointest Surg (2008) 1.45

Do we still need the aminoglycosides? Int J Antimicrob Agents (2008) 1.45

World databases of summaries of articles in the biomedical fields. Arch Intern Med (2007) 1.43

Fluoroquinolones versus beta-lactam based regimens for the treatment of osteomyelitis: a meta-analysis of randomized controlled trials. Spine (Phila Pa 1976) (2008) 1.40

Non-physicians may reach correct diagnoses by using Google: a pilot study. Swiss Med Wkly (2008) 1.40

Worldwide trends in quantity and quality of published articles in the field of infectious diseases. BMC Infect Dis (2005) 1.39

From conference abstract to full paper: differences between data presented in conferences and journals. FASEB J (2005) 1.39

Susceptibility of urinary tract bacteria to fosfomycin. Antimicrob Agents Chemother (2009) 1.38

Pain and a purple lesion. Am J Med (2006) 1.38

Tuberculosis of the oral cavity: a systematic review. Eur J Oral Sci (2010) 1.37

Clinical significance of the pharmacokinetic and pharmacodynamic characteristics of fosfomycin for the treatment of patients with systemic infections. Int J Antimicrob Agents (2009) 1.35

Polymyxin B: similarities to and differences from colistin (polymyxin E). Expert Rev Anti Infect Ther (2007) 1.34

Cure of multidrug-resistant Acinetobacter baumannii bacteraemia with continuous intravenous infusion of colistin. Scand J Infect Dis (2005) 1.33

Age distribution of cases of 2009 (H1N1) pandemic influenza in comparison with seasonal influenza. PLoS One (2011) 1.33

Treatment failure and recurrence of Clostridium difficile infection following treatment with vancomycin or metronidazole: a systematic review of the evidence. Int J Antimicrob Agents (2012) 1.32

Human infections associated with wild birds. J Infect (2007) 1.29

A bibliometric analysis in the fields of preventive medicine, occupational and environmental medicine, epidemiology, and public health. BMC Public Health (2006) 1.27

Mapping health literacy research in the European Union: a bibliometric analysis. PLoS One (2008) 1.25

Infections related to airway stenting: a systematic review. Respiration (2009) 1.21

Linezolid for the treatment of patients with central nervous system infection. Ann Pharmacother (2007) 1.21

Serum procalcitonin as a diagnostic marker for neonatal sepsis: a systematic review and meta-analysis. Intensive Care Med (2011) 1.20

Ciprofloxacin vs an aminoglycoside in combination with a beta-lactam for the treatment of febrile neutropenia: a meta-analysis of randomized controlled trials. Mayo Clin Proc (2005) 1.20

Probiotics for the prevention of respiratory tract infections: a systematic review. Int J Antimicrob Agents (2009) 1.19

Probiotics for the treatment of allergic rhinitis and asthma: systematic review of randomized controlled trials. Ann Allergy Asthma Immunol (2008) 1.18

Treatment of Acinetobacter infections. Expert Opin Pharmacother (2010) 1.18

Aerosolized colistin as adjunctive treatment of ventilator-associated pneumonia due to multidrug-resistant Gram-negative bacteria: a prospective study. Respir Med (2007) 1.17

Frequency, characteristics, and predictors of microbiologically documented nosocomial infections after cardiac surgery. Eur J Cardiothorac Surg (2006) 1.17

Antiviral treatment for severe EBV infections in apparently immunocompetent patients. J Clin Virol (2010) 1.14

Therapeutic options for Burkholderia cepacia infections beyond co-trimoxazole: a systematic review of the clinical evidence. Int J Antimicrob Agents (2008) 1.13

Outcomes after medical and surgical treatment of diverticulitis: a systematic review of the available evidence. J Gastroenterol Hepatol (2007) 1.12

Do psychological variables affect early surgical recovery? PLoS One (2011) 1.11

Stenotrophomonas maltophilia infections in a general hospital: patient characteristics, antimicrobial susceptibility, and treatment outcome. PLoS One (2012) 1.10

Incidence of postoperative infections in patients undergoing coronary artery bypass grafting surgery receiving antimicrobial prophylaxis with original and generic cefuroxime. J Infect (2007) 1.09

Health literacy research in Europe: a snapshot. Eur J Public Health (2005) 1.08

Insights into infectious disease in the era of Hippocrates. Int J Infect Dis (2008) 1.07

Multidrug-resistant Gram-negative bacterial infections: the emerging threat and potential novel treatment options. Curr Opin Investig Drugs (2008) 1.07

World Wide Web resources on control of nosocomial infections. Crit Care (2007) 1.07

Meta-analyses on behavioral interventions to reduce the risk of transmission of HIV. Infect Dis Clin North Am (2009) 1.07

Free internal medicine case-based education through the World Wide Web: how, where, and with what? Mayo Clin Proc (2007) 1.06

Colistin and polymyxin B in critical care. Crit Care Clin (2008) 1.06

Temporal trends in the impact factor of European versus USA biomedical journals. PLoS One (2011) 1.06

Polymyxins: a review of the current status including recent developments. Ann Acad Med Singapore (2008) 1.06

Risk factors for development of Clostridium difficile infection due to BI/NAP1/027 strain: a meta-analysis. Int J Infect Dis (2012) 1.05

Cure of post-traumatic recurrent multiresistant Gram-negative rod meningitis with intraventricular colistin. J Infect (2005) 1.05

Synergy of fosfomycin with other antibiotics for Gram-positive and Gram-negative bacteria. Eur J Clin Pharmacol (2010) 1.05

Risk factors for mesh-related infections after hernia repair surgery: a meta-analysis of cohort studies. World J Surg (2011) 1.05

Clinical assessment and medical treatment of spine infections. Clin Orthop Relat Res (2006) 1.04

World Wide Web hepatitis B virus resources. J Clin Virol (2006) 1.04

Outcome of critically ill oldest-old patients (aged 90 and older) admitted to the intensive care unit. J Am Geriatr Soc (2006) 1.04

Adjunctive therapies for community-acquired pneumonia: a systematic review. J Antimicrob Chemother (2008) 1.03

Use of international units when dosing colistin will help decrease confusion related to various formulations of the drug around the world. Antimicrob Agents Chemother (2006) 1.03

Antifungal prophylaxis with azoles in high-risk, surgical intensive care unit patients: a meta-analysis of randomized, placebo-controlled trials. Crit Care Med (2006) 1.03

Chronic bacterial and parasitic infections and cancer: a review. J Infect Dev Ctries (2010) 1.03

Hyaluronic acid: an effective alternative treatment of interstitial cystitis, recurrent urinary tract infections, and hemorrhagic cystitis? Eur Urol (2007) 1.01

Short- versus long-course antibacterial therapy for community-acquired pneumonia : a meta-analysis. Drugs (2008) 1.01

Infectious complications of monoclonal antibodies used in cancer therapy: a systematic review of the evidence from randomized controlled trials. Cancer (2007) 1.01

Options for treating carbapenem-resistant Enterobacteriaceae. Curr Opin Infect Dis (2014) 1.01

Epidemiologic, clinical characteristics, and risk factors for adverse outcome in multiresistant gram-negative primary bacteremia of critically ill patients. Am J Infect Control (2010) 1.00